WHO. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. WHO
WHO/HSE/EPR/GIP/2008.1
- English - PDF [pdf 159kb]
Contents
Executive summary
1. Characteristics of candidate human H5N1 influenza vaccines
2. Options for using human H5N1 influenza vaccines
3. Options for using the WHO H5N1 vaccine stockpile
See Also:
Latest articles in those days:
- Nomenclature Updates to the Hemagglutinin Gene Clade Designations Resulting From the Continued Evolution of High Pathogenicity Avian Influenza A(H5) Virus Clades 2.3.2.1c and 2.3.4.4 11 hours ago
- Mathematical modeling of in vitro replication dynamics for multiple highly pathogenic avian influenza clade 2.3.4.4 viruses in chicken and duck cells 11 hours ago
- H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves 11 hours ago
- Highly pathogenic avian influenza as a systemic risk - implications for control and preparedness 2 days ago
- Multiple introductions and spread of novel reassortant highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b viruses via wild birds, South Korea, 2024-2025 2 days ago
[Go Top] [Close Window]
